Xiaoyan Xia
Cancer Center And State Key Laboratory Of Biotherapy
Chengdu, China
Chengdu, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Inflammatory bowel disease and hearing loss: A study of Mendelian randomization.
Journal: Medicine
Published: June 02, 2025
An orally available Mpro/TMPRSS2 bispecific inhibitor with potent anti-coronavirus efficacy in vivo.
An orally available Mpro/TMPRSS2 bispecific inhibitor with potent anti-coronavirus efficacy in vivo.
Journal: Research square
Published: November 28, 2024
An orally available Mpro/TMPRSS2 bispecific inhibitor with potent anti-coronavirus efficacy in vivo.
An orally available Mpro/TMPRSS2 bispecific inhibitor with potent anti-coronavirus efficacy in vivo.
Journal: Nature communications
Published: November 14, 2024
Mapping the risk factors, pathogens, and antibiotic of pharyngocutaneous fistula in patients after neck open surgery.
Journal: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
Published: November 23, 2023
DHAV 3CD targets IRF7 and RIG-I proteins to block the type I interferon upstream signaling pathway.
Journal: Veterinary research
Published: September 13, 2022
Functions of Viroporins in the Viral Life Cycle and Their Regulation of Host Cell Responses.
Journal: Frontiers in immunology
Published: March 06, 2022
DHAV-1 Blocks the Signaling Pathway Upstream of Type I Interferon by Inhibiting the Interferon Regulatory Factor 7 Protein.
Journal: Frontiers in microbiology
Published: April 26, 2021
Showing 1-10 of 10
Last Updated: 09/26/2026